Certara to Participate in Upcoming Investor Conferences
Certara (Nasdaq: CERT), a leader in model-informed drug development, has announced its participation in two upcoming investor conferences. The company will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 at 4:05 p.m. ET and the Baird Global Healthcare Conference on September 11 at 10:15 a.m. ET.
Both conference presentations will be available via live webcasts on Certara's investor relations website at https://ir.certara.com. These webcasts will remain accessible for replay for at least 90 days after the events. This participation provides investors with opportunities to gain insights into Certara's operations and future prospects directly from the company's management.
Certara (Nasdaq: CERT), leader nello sviluppo di farmaci basato su modelli, ha annunciato la sua partecipazione a due prossime conferenze per investitori. L'azienda sarà presente alla 22ª Conferenza Annuale Global Healthcare di Morgan Stanley il 4 settembre alle 16:05 ET e alla Conferenza Globale Healthcare di Baird l'11 settembre alle 10:15 ET.
Tutte le presentazioni delle conferenze saranno disponibili tramite webcast dal vivo sul sito web delle relazioni con gli investitori di Certara all'indirizzo https://ir.certara.com. Questi webcast rimarranno accessibili per la replica per almeno 90 giorni dopo gli eventi. Questa partecipazione offre agli investitori l'opportunità di ottenere informazioni sulle operazioni di Certara e sulle prospettive future direttamente dalla direzione dell'azienda.
Certara (Nasdaq: CERT), un líder en el desarrollo de medicamentos basado en modelos, ha anunciado su participación en dos próximas conferencias para inversores. La compañía estará presente en la 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre a las 4:05 p.m. ET y en la Conferencia Global de Salud de Baird el 11 de septiembre a las 10:15 a.m. ET.
Las presentaciones de ambas conferencias estarán disponibles a través de webcasts en vivo en el sitio web de relaciones con inversores de Certara en https://ir.certara.com. Estos webcasts permanecerán accesibles para su repetición durante al menos 90 días después de los eventos. Esta participación brinda a los inversores oportunidades para obtener información sobre las operaciones de Certara y sus perspectivas futuras directamente de la gestión de la empresa.
Certara (Nasdaq: CERT)는 모델 기반의 의약품 개발의 선두주자로서 두 개의 투자자 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사는 9월 4일 오후 4시 5분(ET)에 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참석하고, 9월 11일 오전 10시 15분(ET)에 베어드 글로벌 헬스케어 컨퍼런스에 참석할 것입니다.
두 컨퍼런스 발표는 Certara의 투자자 관계 웹사이트 https://ir.certara.com를 통해 실시간 웹캐스트로 제공될 예정입니다. 이 웹캐스트는 이벤트 이후 최소 90일 동안 다시 시청할 수 있습니다. 이러한 참여는 투자자들에게 Certara의 운영 및 향후 전망에 대한 통찰을 회사 경영진으로부터 직접 얻을 수 있는 기회를 제공합니다.
Certara (Nasdaq: CERT), un leader dans le développement de médicaments informé par modèle, a annoncé sa participation à deux conférences pour investisseurs à venir. La société sera présente à la 22e Conférence Annuelle Mondiale sur les Soins de Santé de Morgan Stanley le 4 septembre à 16h05 ET et à la Conférence Mondiale sur les Soins de Santé de Baird le 11 septembre à 10h15 ET.
Les présentations des deux conférences seront disponibles via des webcasts en direct sur le site web des relations investisseurs de Certara à l'adresse https://ir.certara.com. Ces webcasts resteront accessibles pendant au moins 90 jours après les événements. Cette participation offre aux investisseurs des opportunités d'obtenir des informations sur les opérations de Certara et leurs perspectives futures directement de la direction de l'entreprise.
Certara (Nasdaq: CERT), ein führendes Unternehmen in der modellbasierten Arzneimittelentwicklung, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am 4. September um 16:05 Uhr ET bei der 22. jährlichen Global Healthcare Conference von Morgan Stanley und am 11. September um 10:15 Uhr ET bei der Baird Global Healthcare Conference präsent sein.
Beide Konferenzpräsentationen werden über Live-Webcasts auf der Investor-Relations-Website von Certara unter https://ir.certara.com verfügbar sein. Diese Webcasts werden für mindestens 90 Tage nach den Veranstaltungen zur Wiederholung zugänglich bleiben. Diese Teilnahme bietet Investoren die Möglichkeit, Einblicke in die Aktivitäten von Certara und künftige Perspektiven direkt vom Management des Unternehmens zu erhalten.
- None.
- None.
RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- Morgan Stanley 22nd Annual Global Healthcare Conference
Date and Time: Wednesday, September 4 at 4:05 p.m. ET
- Baird Global Healthcare Conference
Date and Time: Wednesday, September 11 at 10:15 a.m. ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
When is Certara (CERT) participating in the Morgan Stanley Global Healthcare Conference?
What time is Certara (CERT) presenting at the Baird Global Healthcare Conference?
Where can investors watch Certara's (CERT) conference presentations?
How long will Certara's (CERT) conference webcasts be available for replay?
